Department of Neurology, Hospital São Sebastião, Entre Douro e Vouga Hospital Centre, 4720-411 Santa Maria da Feira, Portugal.
Correspondence Address: Dr. Marta Lopes, Department of Neurology, Hospital São Sebastião, Entre Douro e Vouga Hospital Centre, 4720-411 Santa Maria da Feira, Portugal. E-mail:
Dr. Marta Lopes is a neurology resident in Centro Hospitalar de Entre o Douro e Vouga, located at Santa Maria da Feira, a beautiful city in northern Portugal. The areas of scientific interest are headaches, sleep disorders, stroke, neurosonology and neuroimmunology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which allows others to remix, tweak and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Movement disorders of paraneoplastic etiology are very rare, representing solely about 1% of all paraneoplastic neurological syndromes. The most frequently associated carcinoma is small-cell lung cancer, although several others are reported such as hematologic, bowel, breast, prostate and bladder. It was reported an association with CV2/CRMP5, Anti-Hu/ANNA, CASPR2 and Yo antibodies, which are detectable in serum in most cases, isolated or in association.[1-4] However, in a minority of cases an autoantibody cannot be detected. The antibody most frequently associated with paraneoplastic chorea is CV2/CRMP5, followed by Anti-Hu/ANNA. In a PNS EuroNetwork cohort only 1/13 patients presented with unilateral chorea.
We present the case of a 62-year-old woman, smoker, who was observed in a neurology clinic because of involuntary movements of the left arm with one-month evolution, without any other complaint. At neurological examination, it was clear a unilateral chorea of the left limbs, worse in the left arm. The remaining examination was unremarkable. Treatment with risperidone and haloperidol were tried, without any symptom improvement. An etiology was extensively sought. The cerebral magnetic resonance imaging was normal. Hu/ANNA1-Ab and CV2/CRMP5-Ab in serum were negative. The patient refused a search for other antibodies and a lumbar puncture. A thoracic computed tomography revealed a mass in the superior lobe of the left lung. The biopsy allowed the diagnosis of a small-cell lung cancer. The patient started on chemotherapy seven months after the first symptoms and radiotherapy afterwards. Light respiratory complaints (dry cough) started only after the first chemotherapy cycle, approximately nine months after the beginning of the chorea. The chorea improved gradually along the first four cycles of treatment. She remained with occasional weak involuntary movements of the left hand. Unfortunately, eight months after the beginning of the oncological treatment, the disease worsened suddenly and she died a few weeks later.
Although the older age, subacute evolution of the symptoms and lack of response to neuroleptics pointed to a paraneoplastic etiology, the lack of other neurological or systemic symptoms and particularly the strict unilaterality were suggestive of other causes. There are only a few reported cases of isolated unilateral chorea of paraneoplastic etiology.[1,3,4]
Our patient started with chorea several months before the definitive diagnosis of lung cancer was made and manifested respiratory symptoms only a couple months after the beginning of chemotherapy. The most frequently associated antibodies were excluded in serum and we were unable to pursue the investigation because of patient refusal. A higher rate of detection of paraneoplastic autoantibodies in cerebrospinal fluid and serum when compared to serum alone is reported. Therefore, in the present case we can’t exclude an association of the hemichorea with an undetected antibody.
We would like to emphasize the great significance of an extensive and precocious search for an auto-immune and, particularly, paraneoplastic cause in patients with late-onset chorea, even when isolated and/or focal, in order to provide an early diagnosis and a precocious start of oncological treatment, to allow an improvement in the prognosis.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
Written consent was obtained from the patient versed in the article.
This kind of article does not require document for ethics approval.
1. Vigliani MC, Honnorat J, Antoine JC, Vitaliani R, Giometto B, Psimaras D, Franchino F, Rossi C, Graus F; PNS EuroNetwork. Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience. J Neurol 2011;258:2058-68.DOIPubMed
2. Krolak-Salmon P, Androdias G, Meyronet D, Aguera M, Honnorat J, Vighetto A. Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies. Eur J Neurol 2006;13:307-8.DOIPubMed
3. Vynogradova I, Savitski V, Heckmann JG. Hemichorea associated with CASPR2 antibody. Tremor Other Hyperkinet Mov (N Y) 2014;4:239.
4. Vernino S, Tuite P, Adler CH, Meschia JF, Boeve BF, Boasberg P, Parisi JE, Lennon VA. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 2002;51:625-30.DOIPubMed
5. McKeon A, Pittock SJ, Lennon VA. CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology 2011;76:1108-10.DOIPubMedPMC